Cargando…

The side effects of hormonal therapy at the patients with prostate cancer

Prostate cancer is one of most frequent malignant tumours at men. The androgen-deprivation therapy is the part of cancer treatment. It could be used both in the early stage of prostate cancer and in the bone metastates. From this reason the antiandrogen drugs waste systematically grows. Unfortunatel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ziółkowska, Ewa, Zarzycka, Małgorzata, Wiśniewski, Tomasz, Żyromska, Agnieszka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687478/ https://www.ncbi.nlm.nih.gov/pubmed/23788934 http://dx.doi.org/10.5114/wo.2012.32478

Ejemplares similares

The role of postoperative radiotherapy in prostate cancer patients
por: Zarzycka, Małgorzata, et al.
Publicado: (2013)

The Sum of Tumour-to-Brain Ratios Improves the Accuracy of Diagnosing Gliomas Using 18F-FET PET
por: Malkowski, Bogdan, et al.
Publicado: (2015)

Clinical outcomes of an intraoperative surgical margin assessment using the fresh frozen section method in patients with invasive breast cancer undergoing breast-conserving surgery – a single center analysis
por: Nowikiewicz, Tomasz, et al.
Publicado: (2019)

Fertility impairment in radiotherapy
por: Biedka, Marta, et al.
Publicado: (2016)

Cardiovascular effects of hormone therapy for prostate cancer
por: Lester, Jason F, et al.
Publicado: (2015)

Hormone therapy in combination with radiotherapy in the treatment of prostate cancer: why and in which group of patients?
por: Milecki, Tomasz, et al.
Publicado: (2015)

The use of luteinizing hormone-releasing hormone analogues is still an indispensable element of therapy in castrate-resistant prostate cancer
por: Milecki, Tomasz, et al.
Publicado: (2014)

Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer
por: Recine, Federica, et al.
Publicado: (2015)

The role of hormone therapy and chemotherapy in oligometastatic prostate cancer
por: Miura, Yuji, et al.
Publicado: (2019)

Thyroid Hormone Changes Related to Growth Hormone Therapy in Growth Hormone Deficient Patients
por: Kucharska, Anna Małgorzata, et al.
Publicado: (2021)

Long-Term Lithium Therapy: Side Effects and Interactions
por: Ferensztajn-Rochowiak, Ewa, et al.
Publicado: (2023)

Hormone replacement therapy (HRT): indications and side effects
por: Whitehead, MI
Publicado: (2002)

How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy?
por: Turco, Fabio, et al.
Publicado: (2023)

Clinical Benefits of Acupuncture for the Reduction of Hormone Therapy–Related Side Effects in Breast Cancer Patients: A Systematic Review
por: Pan, Yuanqing, et al.
Publicado: (2018)

Hormonal Therapy in Metastatic Prostate Cancer: Current Perspectives and Controversies
por: Garg, Manish, et al.
Publicado: (2013)

Radiotherapy combined with hormonal therapy in prostate cancer: the state of the art
por: Milecki, Piotr, et al.
Publicado: (2010)

Liver Microenvironment Response to Prostate Cancer Metastasis and Hormonal Therapy
por: Buxton, Alison K., et al.
Publicado: (2022)

The Use of Dietary Supplements to Alleviate Androgen Deprivation Therapy Side Effects during Prostate Cancer Treatment
por: Dueregger, Andrea, et al.
Publicado: (2014)

Advances in hormonal therapies for hormone naïve and castration-resistant prostate cancers with or without previous chemotherapy
por: Pham, Thy, et al.
Publicado: (2016)

Predicting side-specific prostate cancer extracapsular extension: a simple decision rule of PSA, biopsy, and MRI parameters
por: Zapała, Piotr, et al.
Publicado: (2019)

The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A quantitative systematic review
por: Fleming, Leanne, et al.
Publicado: (2022)

Hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients
por: Lyou, Yung, et al.
Publicado: (2021)

The effectiveness of lifestyle interventions to reduce side effects of androgen deprivation therapy for men with prostate cancer: a systematic review
por: Geerkens, Maud J. M., et al.
Publicado: (2019)

Unusual side effect from a luteinizing hormone-releasing hormone agonist, leuprorelin, in the treatment of prostate cancer: a case report
por: Chang, John I-Chiang, et al.
Publicado: (2016)

Intervening on the Side Effects of Hormone-Dependent Cancer Treatment: The Role of Strength Training
por: Hanson, Erik D., et al.
Publicado: (2011)

The use of hormonal therapy with radiotherapy for prostate cancer: analysis of prospective randomised trials
por: Gottschalk, A R, et al.
Publicado: (2004)

Systemic therapies for metastatic hormone‐sensitive prostate cancer: network meta‐analysis
por: Mori, Keiichiro, et al.
Publicado: (2021)

Adherence to oral hormonal therapy in advanced prostate cancer: a scoping review
por: Fleshner, Neil E., et al.
Publicado: (2023)

Role of hormonal therapy for prostate cancer: perspective from Japanese experiences
por: Namiki, Mikio, et al.
Publicado: (2012)

Hormonal Effects on Hair Follicles
por: Grymowicz, Monika, et al.
Publicado: (2020)

The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A qualitative systematic review and thematic synthesis
por: Peddie, Nicola, et al.
Publicado: (2021)

Anti-Hormonal Therapy in Breast Cancer and Its Effect on the Blood-Brain Barrier
por: Curtaz, Carolin J., et al.
Publicado: (2022)

Acute pulmonary embolus in the course of cancer
por: Biedka, Marta, et al.
Publicado: (2012)

The Importance of Time to Prostate-Specific Antigen (PSA) Nadir after Primary Androgen Deprivation Therapy in Hormone-Naïve Prostate Cancer Patients
por: Sasaki, Takeshi, et al.
Publicado: (2018)

Docetaxel treatment in the elderly patient with hormone refractory prostate cancer
por: Sinibaldi, Victoria J
Publicado: (2007)

Combination therapy with androgen deprivation for hormone sensitive prostate cancer: A new frontier
por: Etheridge, Tyler, et al.
Publicado: (2019)

Contemporary hormone therapy with LHRH agonists for prostate cancer: avoiding osteoporosis and fracture
por: Wilson, Hannah C.P., et al.
Publicado: (2015)

Effect of Concurrent Gonadotropin-Releasing Hormone Agonist Treatment on Dose and Side Effects of Gender-Affirming Hormone Therapy in Adolescent Transgender Patients
por: Jensen, Rachel K., et al.
Publicado: (2019)

Effect of Growth Hormone Treatment on the Concentration of Selected Metabolic Markers in Girls With Turner Syndrome
por: Błaszczyk, Ewa, et al.
Publicado: (2022)

Erratum to hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q3hkfu3conb9i4tck15nqktovc